Year 2023 Vol. 31 No 2

SCIENTIFIC PUBLICATIONS

N.A. KARPUK 1, S.P. RUBNIKOVICH 2, I.V. ZHYLTSOU 1, O.C. MAZUR 3, I.YU. KARPUK 1, A.P. MIKHALENKA3

SOMATIC MUTATIONS IN ORAL SQUAMOUS CELL CARCINOMAS

Vitebsk State Medical University 1, Vitebsk,
Belorusian State Medical University 2, Republic of Belarus
Institute of Genetics and Cytology of the Belorusian National Academy of Sciences, Laboratory of Environmental Genetics and Biotechnology 3, Minsk,
Republic of Belarus

Objective. The number of cases of oral squamous cell carcinoma (OSCC) is increasing annually all over the world. At the same time, the prediction of the development and early diagnosis of OSCC are consided to be the most important health problems. By using high throughput DNA sequencing (DNA-seq) technologies, it is possible to identify genetic variants that play a role in human health.
Methods. The samples (n=48) of altered oral mucosal epithelium of patients with oral mucosal leukoplakia (n=24) and oral squamous cell carcinomas (n=24) were the material for the study. The QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) was used to isolate DNA from the samples. DNA sequencing was performed with Illumina NextSeq 550 sequencer and TruSight™ Oncology 500 DNA Kit, For Use with NextSeq (Illumina, USA). All operations for DNA extraction from biological samples, preparation of DNA libraries, and sequencing were performed step by step in strict accordance with the instructions supplied with the reagent kits. The bioinformatic analysis was performed by an experienced professional using Illumina BaseSpace and Galaxy Project specialized software and in accordance with current guidelines.
Results. Identified pathogenic and probably pathogenic variants in ERCC3, HOXB13, KRAS, MSH3, MSH6, PIK3CA, and TP53 genes are associated with a high probability (RR 90-22000) of oral squamous cell carcinomas development.
Conclusion. This information allows working out PCR and NGS test systems for predicting the development and early diagnosis of oral squamous cell carcinomas.

Keywords: DNA sequencing, somatic mutations, oral squamous cell carcinomas
p. 137-145 of the original issue
References
  1. van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20(6):e685-e692. Published 2015 Nov 1. doi: 10.4317/medoral.21007.
  2. Kalavrezos N, Scully C. Mouth Cancer for Clinicians. Part 1: Cancer. Dent Update. 2015;42(3):250-260. doi: 10.12968/denu.2015.42.3.250.
  3. Izumchenko E, Sun K, Jones S, Brait M, Agrawal N, Koch W, McCord CL, Riley DR, Angiuoli SV, Velculescu VE, Jiang WW, Sidransky D. Notch1 mutations are drivers of oral tumorigenesis. Cancer Prev Res (Phila). 2015 Apr;8(4):277-286. doi: 10.1158/1940-6207.CAPR-14-0257. Epub 2014 Nov 18.
  4. Novikova MV, Rybko VA, Hromova NV, Farmakovskaja MD, Kopnin PB. The role of Notch proteins in the processes of carcinogenesis. Uspehi molekuljarnoj onkologii. 2015;(3):30-42. (in Russ)
  5. Razavi SM, Jafari M, Heidarpoor M, Khalesi S. Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions. Malays J Pathol. 2015 Dec;37(3):253-8.
  6. Ribeiro IP, Marques F, Barroso L, Rodrigues J, Caramelo F, Melo JB, Carreira IM. Genomic profile of oral squamous cell carcinomas with an adjacent leukoplakia or with an erythroleukoplakia that evolved after the treatment of primary tumor: A report of two cases. Mol Med Rep. 2017 Nov;16(5):6780-6786. doi: 10.3892/mmr.2017.7428. Epub 2017 Sep 5.
  7. Núñez F, Domínguez O, Coto E, Suárez-Nieto C, Pérez P, López-Larrea C. Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck. Surg Oncol. 1992 Dec;1(6):405-11. doi: 10.1016/0960-7404(92)90043-k.
  8. Chung CM, Hung CC, Lee CH, Lee CP, Lee KW, Chen MK, Yeh KT, Ko YC. Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy. PLoS One. 2019 Jan 18;14(1):e0210901. doi: 10.1371/journal.pone.0210901.
  9. QIAamp® DNA FFPE Tissue Handbook [Electronic resource]. Published February 2020 [cited 2022 October 27]. Available from: https://www.qiagen.com/us/products/discovery-and-translational-research/dna-rna-purification/dna-purification/genomic-dna/ qiaamp-dna-ffpe-tissue-kit/
  10. Illumina TruSight Oncology 500 Reference Guide [Electronic resource]. [cited 2021 May 26]. Available from: https://support.illumina.com/content/dam/illumina-support/documents/documentation/chemistry_documentation/trusight/oncology-500/trusight-oncology-500-reference-guide-1000000067621_07.pdf
  11. Kanzi AM, San JE, Chimukangara B, Wilkinson E, Fish M, Ramsuran V, de Oliveira T. Next Generation Sequencing and Bioinformatics Analysis of Family Genetic Inheritance. Front Genet. 2020 Oct 23;11:544162. doi: 10.3389/fgene.2020.544162.
  12. Kajumov AR. Molekuljarnyj analiz genoma [Molecular analysis of the genome]. Kazan: Kazan Federal University; 2016. 60 p. (in Russ)
  13. Fox AJ, Hiemenz MC, Lieberman DB, Sukhadia S, Li B, Grubb J, Candrea P, Ganapathy K, Zhao J, Roth D, Alley E, Loren A, Morrissette JJ. Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors. J Vis Exp. 2016 Sep 20;(115):52758. doi: 10.3791/52758.
  14. Buzdugan L, Kalisch M, Navarro A, Schunk D, Fehr E, Bühlmann P. Assessing statistical significance in multivariable genome wide association analysis. Bioinformatics. 2016 Jul 1;32(13):1990-2000. doi: 10.1093/bioinformatics/btw128. Epub 2016 Mar 7.
  15. Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012 May 1;4(5):a008052. doi: 10.1101/cshperspect.a008052
  16. Ouhtit A, Al-Kindi MN, Kumar PR, Gupta I, Shanmuganathan S, Tamimi Y. Hoxb13, a potential prognostic biomarker for prostate cancer. Front Biosci (Elite Ed). 2016 Jan 1;8(1):40-5. doi: 10.2741/E749. PMID: 26709644
  17. Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn J Basic Med Sci. 2018 Feb 20;18(1):8-20. doi: 10.17305/bjbms.2018.2756
  18. Aburjania Z, Jang S, Whitt J, Jaskula-Stzul R, Chen H, Rose JB. The Role of Notch3 in Cancer. Oncologist. 2018 Aug;23(8):900-911. doi: 10.1634/theoncologist.2017-0677. Epub 2018 Apr 5.
  19. Ibrahim A, Chopra S. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors. Arch Pathol Lab Med. 2020 May;144(5):655-660. doi: 10.5858/arpa.2018-0370-RS. Epub 2019 Jun 6.
  20. Mercado-Asis LB, Wolf KI, Jochmanova I, Taïeb D. Pheochromocytoma: a genetic and diagnostic update. Endocr Pract. 2018 Jan;24(1):78-90. doi: 10.4158/EP-2017-0057. Epub 2017 Nov 16.
  21. Liu B, Wang T, Wang H, Zhang L, Xu F, Fang R, Li L, Cai X, Wu Y, Zhang W, Ye L. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol. 2018 Feb 23;11(1):26. doi: 10.1186/s13045-018-0577-5
  22. Ouhtit A, Al-Kindi MN, Kumar PR, Gupta I, Shanmuganathan S, Tamimi Y. Hoxb13, a potential prognostic biomarker for prostate cancer. Front Biosci (Elite Ed). 2016 Jan 1;8(1):40-5. doi: 10.2741/E749. PMID: 26709644.
  23. Griffith M, Spies NC, Krysiak K, McMichael JF, Coffman AC, Danos AM, Ainscough BJ, Ramirez CA, Rieke DT, Kujan L, Barnell EK, Wagner AH, Skidmore ZL, Wollam A, Liu CJ, Jones MR, Bilski RL, Lesurf R, Feng YY, Shah NM, Bonakdar M, Trani L, Matlock M, Ramu A, Campbell KM, Spies GC, Graubert AP, Gangavarapu K, Eldred JM, Larson DE, Walker JR, Good BM, Wu C, Su AI, Dienstmann R, Margolin AA, Tamborero D, Lopez-Bigas N, Jones SJ, Bose R, Spencer DH, Wartman LD, Wilson RK, Mardis ER, Griffith OL. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat Genet. 2017 Jan 31;49(2):170-174. doi: 10.1038/ng.3774.
  24. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
  25. The Genome Aggregation Database (gnomAD) [Electronic resource]. [cited 2022 July 25]. Available from: https://gnomad.broadinstitute.org
  26. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):776-81. doi: 10.1073/pnas.0334858100. Epub 2003 Jan 27.
  27. Loeb KR, Loeb LA. Significance of multiple mutations in cancer. Carcinogenesis. 2000 Mar;21(3):379-85. doi: 10.1093/carcin/21.3.379.
  28. Saito Y, Koya J, Kataoka K. Multiple mutations within individual oncogenes. Cancer Sci. 2021 Feb;112(2):483-489. doi: 10.1111/cas.14699. Epub 2021 Jan 11.
  29. Nussinov R, Tsai CJ, Jang H. How can same-gene mutations promote both cancer and developmental disorders? Sci Adv. 2022 Jan 14;8(2):eabm2059. doi: 10.1126/sciadv.abm2059. Epub 2022 Jan 14.
Address for correspondence:
210009, Republic of Belarus,
Vitebsk, Frunze Ave., 27,
Vitebsk State Medical University,
tel.: +375-29-596-10-83,
e-mail: ms.karpuk@mail.ru,
Karpuk Natalia A.
Information about the authors:
Karpuk Natalia A., PhD, Associate Professor, Associate Professor of the Department of General and Orthopedic Dentistry with the Course of FAT and RP Vitebsk State Medical University, Vitebsk, Republic of Belarus.
http://orcid.org/0000-0001-9991-7034
Rubnikovich Sergey P. Corresponding Member of NASB, MD, Professor, Rector of Belarusian State Medical University, Minsk, Republic of Belarus.
http://orcid.org/0000-0002-7450-3757
Zhyltsou Ivan V, MD, Professor, Head of the Department of Evidence-Based Medicine and Clinical Diagnostics of the Faculty of Advanced Training and Retraining of Vitebsk State Medical University, Vitebsk, Republic of Belarus.
http://orcid.org/0000-0002-4912-2880
Mazur Oksana C., Researcher, Laboratory of Environmental Genetics and Biotechnology, Institute of Genetics and Cytology of the National Academy of Sciences of Belarus, Minsk, Belarus
http://orcid.org/0000-0002-6093-4548
Karpuk Ivan Yu., MD, Dean of the Faculty of Dentistry, Professor of the Department of General Dentistry with the Course of Prosthodontic Dentistry of. Vitebsk State Medical University, Vitebsk, Republic of Belarus.
http://orcid.org/0000-0001-9991-7035
Mikhalenka Alena P., PhD (Biol.), Senior Researcher, Laboratory of Environmental Genetics and Biotechnology, Institute of Genetics and Cytology of the National Academy of Sciences of Belarus , Minsk, Belarus.
http://orcid.org/0000-0003-4543-2862.
Contacts | ©Vitebsk State Medical University, 2007-2023